Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001019687-16-004873
Filing Date
2016-01-19
Accepted
2016-01-19 17:32:22
Documents
73
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 pharmacyte_10ka2-043015.htm 10-K/A 1224957
2 CERTIFICATION pharmacyte_10k-ex3101.htm EX-31.1 8793
3 CERTIFICATION pharmacyte_10k-ex3201.htm EX-32.1 4666
  Complete submission text file 0001019687-16-004873.txt   5129777

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pmcb-20150430.xml EX-101.INS 1003991
5 XBRL SCHEMA FILE pmcb-20150430.xsd EX-101.SCH 41851
6 XBRL CALCULATION FILE pmcb-20150430_cal.xml EX-101.CAL 64014
7 XBRL DEFINITION FILE pmcb-20150430_def.xml EX-101.DEF 144905
8 XBRL LABEL FILE pmcb-20150430_lab.xml EX-101.LAB 290534
9 XBRL PRESENTATION FILE pmcb-20150430_pre.xml EX-101.PRE 263699
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-K/A | Act: 34 | File No.: 333-68008 | Film No.: 161349189
SIC: 2833 Medicinal Chemicals & Botanical Products